Functional Neurological Disorder Clinical Trial
Official title:
A Feasibility Study for a Psycho-education Intervention for People With a Functional Neurological Disorder.
Verified date | October 2019 |
Source | University of Edinburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to assess the feasibility of running a brief psychoeducation group intervention in an outpatient setting to assess the practicalities and benefits of offering this type of intervention for both clinicians and patients
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | September 2020 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility |
Inclusion Criteria: - Individuals aged between 18-64 years with a diagnosis of FND Exclusion Criteria: - Anyone the clinical neuropsychologist/neurologist feels, as a result of their clinical judgement, lacks capacity to consent. - People who are unable to understand the information sheet due to English not being their first language. - Severe sensory impairment. - Anyone experiencing active severe psychiatric symptoms - A dependency on alcohol or recreational drugs - Learning disability as classified by ICD 10. - Those unable to travel independently to attend group sessions due to the severity of their symptoms |
Country | Name | City | State |
---|---|---|---|
United Kingdom | NHS Grampian | Aberdeen |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | NHS Grampian |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Medical Outcome Study 36-item Short Form Health Survey (SF-36) | This outcome will measure potential change in self-reported health related quality of life using eight subscales | Baseline, Change from Baseline at Time 1 (2 weeks prior to group), Change from Baseline at Time 2 (4 weeks after Time 1), Time 3 change from baseline 3 months from Time 2 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04310670 -
Integrated Treatment in FND (Functional Neurological Disorders)
|
N/A | |
Not yet recruiting |
NCT06346873 -
Demonstrating Efficacy of JOGO for the Treatment of Tremor
|
N/A | |
Active, not recruiting |
NCT05941702 -
Body Signal Integration Training: A Case Series
|
N/A | |
Recruiting |
NCT06084325 -
The Role of Oxytocin and Interoception in Functional Neurological Disorder
|
||
Active, not recruiting |
NCT05581810 -
Rehabilitation for Functional Memory Symptoms After Concussion
|
N/A | |
Completed |
NCT03325374 -
BLB Study Back or Leg Pain and Bladder Symptoms Study
|
||
Recruiting |
NCT06149728 -
Pain Assessment and Transcranial Magnetic Stimulation Tolerability in Patients With a Functional Neurological Disorder
|
||
Terminated |
NCT02764476 -
Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder
|
N/A | |
Not yet recruiting |
NCT06362161 -
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
|
||
Terminated |
NCT03731078 -
Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders
|
||
Not yet recruiting |
NCT05731648 -
Role of Functional Neurosurgery in Management of Spasticity
|
||
Not yet recruiting |
NCT06422819 -
Clinical Evaluation of HRV Biofeedback in Functional Neurological Disorders Compared to Placebo
|
N/A | |
Completed |
NCT05634486 -
Efficacy of the Multidisciplinary Treatment to the Quality of Life of With Functional Movement Disorders
|
N/A | |
Not yet recruiting |
NCT05723276 -
Psilocybin in Functional Neurological Disorder
|
N/A | |
Recruiting |
NCT06257069 -
Tremor Retrainer Software Application for Functional Tremor
|
N/A | |
Completed |
NCT04942600 -
Behavioural and Electrophysiological Effects of rTMS in Functional Neurological Disorders
|
N/A | |
Recruiting |
NCT06105996 -
ADIE-FS - Aligning Dimensions of Interoceptive Experience in Patients With Functional Seizures
|
N/A |